Close Menu

NEW YORK ─ Hologic on Monday said it has priced its previously announced $950 million private offering of 3.250 percent senior notes due in 2029 at an issue price of $1,000 per $1,000.

Marlborough, Massachusetts-based Hologic intends to use the proceeds of the offering and available cash to refinance its existing 4.375 percent senior unsecured notes due 2025 and will use current cash to pay transaction-related premiums, fees, and expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.